Cargando…
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
SIMPLE SUMMARY: Since immune cells were found to attack cancer cells, strategies have been developed to sustain anti-cancer immune functions to prevent them from becoming exhausted in the midst of war. Immune checkpoint blockade therapy has gained significant traction with its ability to fast-track...
Autores principales: | Tay, Christopher, Qian, Yamin, Sakaguchi, Shimon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796137/ https://www.ncbi.nlm.nih.gov/pubmed/33375291 http://dx.doi.org/10.3390/cancers13010048 |
Ejemplares similares
-
Is Weak Acid Beneficial for Addressing Checkpoint
Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1
Immunotherapies?
por: Wan, Yulin, et al.
Publicado: (2020) -
PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
por: Kamada, Takahiro, et al.
Publicado: (2019) -
Soft Foil and Progressive Dentistry
por: Davis, E. B.
Publicado: (1889) -
Radio-Immunotherapy: A Case Report of ‘Abscopal Hyper-Progression’?
por: Koukourakis, Ioannis M, et al.
Publicado: (2020) -
Taking regulatory T cells into medicine
por: Sakaguchi, Shimon
Publicado: (2021)